This inventor holds 1 USPTO granted patent. Top assignee: Ares Capital Corporation, as Agent. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Kevin Smith - Innovator in Synthetic Gene Technology
Introduction
Kevin Smith is an accomplished inventor based in Franklin, MA (US). He has made significant contributions to the field of synthetic gene technology. His innovative work has led to the development of a patent that addresses critical challenges in gene assembly and error reduction.
Latest Patents
Kevin holds a patent titled "Assembly and Error Reduction of Synthetic Genes from Oligonucleotides." This patent is a testament to his expertise and dedication to advancing genetic engineering. He has 1 patent to his name, showcasing his commitment to innovation in this specialized area.
Career Highlights
Kevin is currently employed at Ares Capital Corporation as an Agent. His role involves leveraging his technical knowledge to contribute to the company's objectives. His work at Ares Capital Corporation allows him to apply his inventive skills in a practical setting.
Collaborations
Throughout his career, Kevin has collaborated with talented individuals such as Marcus R Duvall and Robin Huang. These partnerships have enriched his work and fostered a collaborative environment that encourages innovation.
Conclusion
Kevin Smith is a notable inventor whose work in synthetic gene technology has made a significant impact. His patent and career at Ares Capital Corporation reflect his dedication to advancing the field. His contributions continue to inspire future innovations in genetic engineering.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile